Unraveling enhanced brain delivery of paliperidone-loaded lipid nanoconstructs: pharmacokinetic, behavioral, biochemical, and histological aspects

References

• Abdelwahed W, Degobert G, Fessi H. (2006). Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm 63:87–94.
   PubMed Web of Science ®Google Scholar
• Agrawal M, Saraf S, Pradhan M, et al. (2021). Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design. Biomed Pharmacother 141:111919.
   PubMed Web of Science ®Google Scholar
• Alam T, Pandit J, Vohora D, et al. (2015). Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy. Expert Opin Drug Deliv 12:181–94.
   PubMed Web of Science ®Google Scholar
• Ali m, Alam M, Alam N, et al. (2013). Accelerated stability testing of a clobetasol propionate-loaded nanoemulsion as per ICH guidelines. Sci Pharm 81:1089–100.
   PubMedGoogle Scholar
• Anand A, Arya M, Kaithwas G, et al. (2019). Sucrose stearate as a biosurfactant for development of rivastigmine containing nanostructured lipid carriers and assessment of its activity against dementia in C. elegans model. J Drug Deliv Sci Technol 49:219–26.
   Web of Science ®Google Scholar
• Aricioglu F, Sahin Ozkartal C, Unal G, et al. (2016). Neuroinflammation in schizophrenia: a critical review and the future. Klinik Psikofarmakol Bulteni-Bull Clin Psychopharmacol 26:329–444.
   Google Scholar
• Bellettato CM, Scarpa M. (2018). Possible strategies to cross the blood-brain barrier. Ital J Pediatr 44:131.
   PubMed Web of Science ®Google Scholar
• Caruso G, Grasso M, Fidilio A, et al. (2020). Antioxidant properties of second-generation antipsychotics: focus on microglia. Pharmaceuticals 13:457.
   Web of Science ®Google Scholar
• Demirci K, Özçankaya R, Yilmaz HR, et al. (2015). Paliperidone regulates intracellular redox system in rat brain: role of purine mechanism. Redox Rep 20:170–6.
   PubMed Web of Science ®Google Scholar
• Dolder C, Nelson M, Deyo Z. (2008). Paliperidone for schizophrenia. Am J Health Syst Pharm 65:403–13.
   PubMed Web of Science ®Google Scholar
• Eleraky NE, Omar MM, Mahmoud HA, Abou-Taleb HA. (2020). Nanostructured lipid carriers to mediate brain delivery of temazepam: design and in vivo study. Pharmaceutics 12:451.
   PubMedGoogle Scholar
• El-Sayed El-Sisi A, Sokkar SS, El-Sayed El-Sayad M, et al. (2016). Celecoxib and omega-3 fatty acids alone and in combination with risperidone affect the behavior and brain biochemistry in amphetamine-induced model of schizophrenia. Biomed Pharmacother 82:425–31.
   PubMed Web of Science ®Google Scholar
• Fatima N, Rehman S, Nabi B, et al. (2019). Harnessing nanotechnology for enhanced topical delivery of clindamycin phosphate. J Drug Deliv Sci Technol 54:101253.
   Web of Science ®Google Scholar
• Garg B, Beg S, Kumar R, et al. (2019). Nanostructured lipidic carriers of lopinavir for effective management of HIV-associated neurocognitive disorder. J Drug Deliv Sci Technol 53:101220.
   Web of Science ®Google Scholar
• Gründer G, Heinze M, Cordes J, et al. (2016). Effects of first-generation antipsychotics versus second-generation antipsychotics on quality of life in schizophrenia: a double-blind, randomised study. Lancet Psychiat 3:717–29.
   PubMed Web of Science ®Google Scholar
• Gueroui M, Kechrid Z. (2016). Evaluation of some biochemical parameters and brain oxidative stress in experimental rats exposed chronically to silver nitrate and the protective role of vitamin E and selenium. Toxicol Res 32:301–9.
   PubMed Web of Science ®Google Scholar
• Iqbal B, Ali J, Ganguli M, et al. (2019). Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer. Nanomedicine 14:1077–93.
   PubMed Web of Science ®Google Scholar
• Iqubal A, Sharma S, Najmi AK, et al. (2019). Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: Plausible role of Nrf2 and NF- κB. Life Sci 236:116867.
   PubMed Web of Science ®Google Scholar
• Jones T, Van Breda K, Charles B, et al. (2009). Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders. Biomed Chromatogr 23:929–34.
   PubMed Web of Science ®Google Scholar
• Khaleeq N, Din FU, Khan AS, et al. (2020). Development of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product. J Microencapsul 37:160–9.
   PubMed Web of Science ®Google Scholar
• Khan N, Shah FA, Rana I, et al. (2020). Nanostructured lipid carriers-mediated brain delivery of carbamazepine for improved in vivo anticonvulsant and anxiolytic activity. Int J Pharm 577:119033.
   PubMed Web of Science ®Google Scholar
• Khan S, Shaharyar M, Fazil M, et al. (2016). Tacrolimus-loaded nanostructured lipid carriers for oral delivery-in vivo bioavailability enhancement. Eur J Pharm Biopharm 109:149–57.
   PubMed Web of Science ®Google Scholar
• Khan SA, Rehman S, Nabi B, et al. (2020). Boosting the brain delivery of atazanavir through nanostructured lipid carrier-based approach for mitigating NeuroAIDS. Pharmaceutics 12:1059.
   PubMed Web of Science ®Google Scholar
• Le Tiec C, Barrail A, Goujard C, Taburet AM. (2005). Clinical pharmacokinetics and summary of efficacy and tolerability of atazanavir. Clin Pharmacokinet 44:1035–50.
   PubMed Web of Science ®Google Scholar
• MacDowell KS, Caso JR, Martín-Hernández D, et al. (2016). The atypical antipsychotic paliperidone regulates endogenous antioxidant/anti-inflammatory pathways in rat models of acute and chronic restraint stress. Neurotherapeutics 13:833–43.
   PubMed Web of Science ®Google Scholar
• Mandpe L, Kyadarkunte A, Pokharkar V. (2013). Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential. Ther Deliv 4:1365–83.
   PubMedGoogle Scholar
• Mandpe L, Pokharkar V. (2015). Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement. Pharm Dev Technol 20:320–9.
   PubMed Web of Science ®Google Scholar
• Miao Y-B, Chen K-H, Chen CT, et al. (2021). A noninvasive gut-to-brain oral drug delivery system for treating brain tumors. Adv Mater 33:e2100701.
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. (1972). The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247:3170–5.
   PubMed Web of Science ®Google Scholar
• Misra S, Chopra K, Sinha VR, Medhi B. (2016). Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations. Drug Deliv 23:1434–43.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Sahu AK, Sonali; Abdulla A, et al. (2016). Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Deliv 23:230–7.
   PubMed Web of Science ®Google Scholar
• Nabi B, Rehman S, Fazil M, et al. (2020). Riluzole-loaded nanoparticles to alleviate the symptoms of neurological disorders by attenuating oxidative stress. Drug Dev Ind Pharm 46:471–83.
   PubMed Web of Science ®Google Scholar
• Natarajan J, Baskaran M, Humtsoe LC, et al. (2017). Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles. Artif Cells Nanomed Biotechnol 45:364–71.
   PubMed Web of Science ®Google Scholar
• Neupane YR, Srivastava M, Ahmad N, et al. (2014). Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment. Int J Pharm 477:601–12.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–8. doi:(79)90738-3.
   PubMed Web of Science ®Google Scholar
• Patel MR, Patel RB, Bhatt KK, et al. (2016). Paliperidone microemulsion for nose-to-brain targeted drug delivery system: pharmacodynamic and pharmacokinetic evaluation. Drug Deliv 23:346–54.
   PubMed Web of Science ®Google Scholar
• Pınar N, Akillioglu K, Sefil F, et al. (2015). Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801. Bosn J Basic Med Sci 15:74–9.
   PubMed Web of Science ®Google Scholar
• Praveen S, Gowda D, Kundachira Subramani N, et al. (2019). Direct brain targeted nanostructured lipid carriers for sustained release of schizophrenic drug: formulation, characterization and pharmacokinetic studies. IJPER 54:73–84.
   Web of Science ®Google Scholar
• Radaic A, Martins-de-Souza D. (2020). The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment. Nanomedicine 28:102222.
   PubMed Web of Science ®Google Scholar
• Rahman HS, Rasedee A, Othman HH, et al. (2014). Acute toxicity study of zerumbone-loaded nanostructured lipid carrier on BALB/c mice model. Biomed Res Int 2014:563930.
   PubMed Web of Science ®Google Scholar
• Rana I, Khan N, Ansari MM, et al. (2020). Solid lipid nanoparticles-mediated enhanced antidepressant activity of duloxetine in lipopolysaccharide-induced depressive model. Colloids Surf B Biointerfaces 194:111209.
   PubMed Web of Science ®Google Scholar
• Rehman S, Nabi B, Baboota S, Ali J. (2021). Tailoring lipid nanoconstructs for the oral delivery of paliperidone: formulation, optimization and in vitro evaluation. Chem Phys Lipids 234:105005.
   PubMed Web of Science ®Google Scholar
• Rubab S, Naeem K, Rana I, et al. (2021). Enhanced neuroprotective and antidepressant activity of curcumin-loaded nanostructured lipid carriers in lipopolysaccharide-induced depression and anxiety rat model. Int J Pharm 603:120670.
   PubMed Web of Science ®Google Scholar
• Sharma S, Khan V, Najmi A, et al. (2018). Prophylactic treatment with icariin prevents isoproterenol-induced myocardial oxidative stress via nuclear factor-like 2 activation. Phcog Mag 14:227–36.
   Web of Science ®Google Scholar
• Singh SK, Dadhania P, Vuddanda PR, et al. (2016). Intranasal delivery of asenapine loaded nanostructured lipid carriers: formulation, characterization, pharmacokinetic and behavioural assessment. RSC Adv 6:2032–45.
   Web of Science ®Google Scholar
• Singh SK, Hidau MK, Gautam S, et al. (2018). Glycol chitosan functionalized asenapine nanostructured lipid carriers for targeted brain delivery: pharmacokinetic and teratogenic assessment. Int J Biol Macromol 108:1092–100.
   PubMed Web of Science ®Google Scholar
• Sinha AK. (1972). Colorimetric assay of catalase. Anal Biochem 47:389–94.
   PubMed Web of Science ®Google Scholar
• Sykes DA, Moore H, Stott L, et al. (2017). Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors. Nat Commun 8:763.
   PubMed Web of Science ®Google Scholar
• Tendilla-Beltrán H, Sanchez-Islas NDC, Marina-Ramos M, et al. (2021). The prefrontal cortex as a target for atypical antipsychotics in schizophrenia, lessons of neurodevelopmental animal models. Prog Neurobiol 199:101967.
   PubMed Web of Science ®Google Scholar
• Vasconcelos GS, Ximenes NC, de Sousa CN, et al. (2015). Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms. Schizophr Res 165:163–70.
   PubMed Web of Science ®Google Scholar
• Vitorino C, Silva S, Gouveia F, et al. (2020). QbD-driven development of intranasal lipid nanoparticles for depression treatment. Eur J Pharm Biopharm 153:106–20.
   PubMed Web of Science ®Google Scholar
• Volkan K. (2020). Schizophrenia: epidemiology, causes, neurobiology, pathophysiology, and treatment. J Health Med Sci 3:487–521.
   Google Scholar
• Wesołowska A, Jastrzębska-Więsek M, Cios A, Partyka A. (2020). The preclinical discovery and development of paliperidone for the treatment of schizophrenia. Expert Opin Drug Discov 15:279–92.
   PubMed Web of Science ®Google Scholar
• Xie R, Xie J, Ye Y, et al. (2020). mTOR expression in hippocampus and prefrontal cortex is downregulated in a rat model of schizophrenia induced by chronic administration of ketamine. J Mol Neurosci 70:269–75.
   PubMed Web of Science ®Google Scholar
• Yu G, Ali Z, Sajjad Khan A, et al. (2021). Ud Din, F. Preparation, pharmacokinetics, and antitumor potential of miltefosine-loaded nanostructured lipid carriers. IJN 16:3255–73.
   Web of Science ®Google Scholar
• Zameer S, Alam M, Hussain S, et al. (2020). Neuroprotective role of alendronate against APP processing and neuroinflammation in mice fed a high fat diet. Brain Res Bull 161:197–212.
   PubMed Web of Science ®Google Scholar